Armed with readouts from the PURPOSE 1 and 2 trials, Gilead Sciences is now gearing up for global regulatory submissions for lenacapavir as a pre-exposure prophylactic option for human immunodeficiency virus.
Tag Archive for: PrEP
In an effort to understand the factors contributing to HIV transmission among sexual and gender minority individuals and improve HIV prevention strategies, a team of scientists led a four-year national cohort study of cisgender men and transgender individuals who have sex with men. Key among their aims was uncovering the reasons why many SGM individuals are not fully benefiting from HIV Pre-Exposure Prophylaxis.
A federal judge in Texas on Thursday blocked Obamacare’s mandate that health insurance plans cover preventive care, including screenings for certain cancers and pre-exposure prophylaxis against HIV (PrEP), at no cost to patients.